Sepsis: A new hypothesis for pathogenesis of the disease process

Chest

Volumn 112, Issue 1, 1997, Pages 235-243

  Bone, Roger C ^a   Grodzin, Charles J ^a   Balk, Robert A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; IMMUNE RESPONSE; MACROPHAGE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS;

EID: 0030843156     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.1.235     Document Type: Article

References (57)

1. Tran DD, Groenveld AB, van der Meulen J, et al. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990; 18:474-79
2. Marshall JC, Cook DJ, Christou NC, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-52
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and multiple organ failure, and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74
4. Bone RC. Why sepsis trials fail. JAMA 1996; 276:565-66
5. Livingston DH, Appel SH, Wellhausen SH, et al. Depressed interferon-gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988; 123:1309-13
6. Cheadle WG, Hershman MJ, Wellhausen SR, et al. Role of monocytic HLA-DR expression following trauma in predicting clinical outcome. In: Faist E, Ninnemann J, Green D, eds. Immune consequences of trauma, shock and sepsis. New York: Springer Verlag, 1989; 119-22
7. Gibbons RA, Martinez OM, Lim OC, et al. Reduction in HLA-DR, HLA-DQ, and HLA-DP expression by Leu-M3+ cells from the peripheral blood of patients with thermal injury. Injury 1989; 19:263-66
8. Wakefield CH, Carey PD, Foulds S, et al. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993; 80:205-09
9. Broader W, Williams D, Pretus H, et al. Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg 1990; 211:605-12
10. Goris JA, te Boekhorst TPA, Nuytinck JKS, et al. Multiple-organ failure: generalized antodestructive inflammation? Arch Surg 1985; 120:1109-15
11. Pinsky MR, Vincent J-L, Deviere J, et al. Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest 1993; 103:565-75
12. Dinarello CA, Gelland JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269:1829-35
13. Goldie AS, Fearon KCH, Ross JA, et al. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. JAMA 1995; 274:172-77
14. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: role of extra-thoracic injury and sepsis in adult respiratory-distress syndrome. New Horizons 1993; 1:538-49
15. Bone RC, Balk RA, Fein AM, et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized clinical trial. Crit Care Med 1995; 23:994-1006
16. Greenman RI, Schein RM, Martin MA, et al. A controlled trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis. JAMA 1991; 266: 1097-1102
17. McCloskey RV, Straube RC, Sanders C, et al. Treatment of septic shock with human monoclonal antibody HA-1A: a randomized double-blind, placebo-controlled trial. Ann Intern Med 1994; 121:1-5
18. Ziegler EJ, Fisher CJ, Sprung CL, et al. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991; 324:429-36
19. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996; 24:163-72
20. Zuckerman SH, Bendele AM. Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models. Infect Immun 1989; 57:3009-13
21. Zedler S, Bone RC, v. Donnersmarck GH, et al. T-cell reactivity and its predictive role in immunosuppression after burns (submitted)
22. Balk RA, Jacobs RF, Tryka AF, et al. Effect of ibuprofen on neutrophil function and acute lung injury in canine endotoxin shock. Crit Care Med 1988; 15:1121-24
23. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans in the administration of endotoxin. N Engl J Med 1989; 321:280-87
24. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-69
25. Munoz C, Carlet J, Fitting C, et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88:1747-54
26. Keogh C, Fong Y, Marano MA, et al. Identification of a novel tumor necrosis factor a/cachectin from the livers of burned and infected rats. Arch Surg 1990; 125:79-85
27. Remick DG. Applied molecular biology of sepsis. J Crit Care 1995; 10:198-212
28. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 272:117-23
29. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996; 125:680-87
30. Fisher CJ, Dhainaut JF, Opal SM, et al. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. JAMA 1994; 271:1836-44
31. Abraham K, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factors in patients with sepsis syndrome. JAMA 1995; 273: 934-37
32. Platzer C, Meisel C, Vogt K, et al. Up-regulation of monocytic IL-10 by tumor necrosis factors and cAMP elevating drugs. Intern Immunol 1995; 7:17-23
33. Fukushima R, Alexander JW, Gianotti L, et al. Isolated pulmonary infection acts as a source of systemic tumor necrosis factor. Crit Care Med 1994; 22:114-20
34. Ford HR, Hoffman HA, Wing EJ, et al. Characterization of wound cytokines in the sponge matrix model. Arch Surg 1989; 124:1422-28
35. Meduri GU, Kohler G, Headley S, et al. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts a poor outcome. Chest 1995; 108:1303-14
36. Sauder DN, Semple J, Truscott D, et al. Stimulation of muscle protein degradation by murine and human epidermal cytokines: relationship to thermal injury. J Invest Dermatol 1986; 87:711-14
37. Kupper TS, Deitch EA, Baker CC, et al. The human burn wound as a primary source of interleukin-1 activity. Surgery 1986; 100:409-14
38. Puren AJ, Feldman C, Savage N, et al. Patterns of cytokine expression in community-acquired pneumonia. Chest 1995; 107:1342-49
39. Traces KJ, Lowry SF, Ceremi A. Cachectin/TNF-alpha in septic shock and adult respiratory distress syndrome [editorial]. Am Rev Respir Dis 1988; 138:1377-79
40. Stephens KE, Ishikaza A, Larrick JW, et al. Tumor necrosis factor causes increased pulmonary permeability and edema: comparison to septic acute lung injury. Am Rev Respir Dis 1988; 137:1364-70
41. 2 in endotoxin shock are unrelated to effects of PAF-acether synthesis. Prostaglandins 1989; 37:237-50
42. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323:645-55
43. Petrak RA, Balk RA, Bone RC. Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthesis inhibitors in the pathogenesis of multiple organ failure. Crit Care Clin 1989; 35:303-14
44. Sigurdsson GH, Christenson JT, Bader el-Rakshy M, et al. Intestinal platelet trapping after traumatic and septic shock: an early sign of sepsis and multiorgan failure in critically ill patients? JAMA 1992; 20:458-67
45. Cipolle MD, Pasquale NM, Cerra FB. Secondary organ dysfunction: from clinical perspectives to molecular mediators. Crit Care Clin 1993; 9:261-98
46. Rinaldo JE, Gorry M, Streiter R, et al. Effect of endotoxin-induced cell injury on 70-kD heat shock proteins in bovine lung endothelial cells. Am J Respir Cell Mol Biol 1990; 3:207-16
47. Levi M, ten Cate H, van der Poll T, et al. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270:975-79
48. Gomez-Jimenez J, Salgado A, Mourelle M, et al. L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23:253-58
49. Miyauchi T, Tomobe Y, Shiba R, et al. Involvement of endothelin in the regulation of human vascular tonus. Circulation 1990; 81:1874-80
50. Randow F, Syrbe U, Meisel C, et al. Mechanism of endotoxin desensitization: involvement of interleukin-10 and transforming growth factor beta. J Exp Med 1995; 181:1887-92
51. Syrbe U, Meinecke A, Platzer C, et al. Improvement of monocyte function - a new therapeutic approach? In: Sepsis: current perspectives in pathophysiology and therapy. New York: Springer Verlag, 1994; 473-500
52. Mills CD, Caldwell NM, Gann DJ. Evidence of a plasma-mediated "window" of immunodeficiency in rats following trauma. J Clin Immunol 1989; 9:139-50
53. Hamilton G, Hofbauer S, Hamilton B. TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intra-abdominal sepsis. Scand J Infect Dis 1992; 24:361-68
54. Kox WJ, Bone RC, Krausch D, et al. Interferon-γ in the treatment of the compensatory anti-inflammatory response syndrome (CARS) - a new approach: proof of principle. Arch Intern Med 1997; 157:389-93
55. Fisher CJ Jr, Opal SM, Dhainaut JF, et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 1993; 21:318-27
56. Dofferhoff AS, Vom VJ, de Vries-Hospers HG, et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20:185-92
57. Lesser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991; 101:782-85